Erythrocyte-Based Pig-a Gene Mutation Assay

Jeffrey C Bemis1, Nikki E Hall2, Stephen D Dertinger2

  • 1Litron Laboratories, Rochester, NY, USA. jbemis@litronlabs.com.

Insights

The Pig-a gene mutation assay detects genotoxicity by analyzing red blood cell surface proteins. This method is crucial for preclinical safety testing during drug development.

Area of Science:

  • Toxicology
  • Genetics
  • Biochemistry

Background:

  • Genotoxicity testing is vital for preclinical safety assessment.
  • Gene mutation assays complement chromosomal damage analysis.
  • The Pig-a gene assay identifies mutations via loss of cell surface protein expression.

Purpose of the Study:

  • To describe a method for Pig-a gene mutation assessment.
  • To detail the use of MutaFlow kits for flow cytometric analysis.
  • To outline the processing of peripheral blood samples for genotoxicity testing.

Main Methods:

  • Utilizing the Pig-a gene mutation assay.
  • Employing flow cytometry for cell surface phenotype analysis.
  • Processing peripheral blood samples with MutaFlow kits.

Main Results:

  • The Pig-a assay effectively identifies gene mutations.
  • Flow cytometry allows for efficient assessment of cell surface protein expression.
  • The described procedure enables reliable genotoxicity testing.

Conclusions:

  • The Pig-a gene mutation assay is a valuable tool in genotoxicity testing.
  • Flow cytometric analysis of red blood cells provides a robust method for detecting mutations.
  • This protocol facilitates preclinical safety evaluation.